Artivion plans new $18,600,000.00 expansion project in Austin, Texas

Austin, Texas — According to state and local development sources, Artivion plans to invest $18,600,000.00 to build out 96,820 square feet of new space in Austin. The company plans to occupy the new space at 1200 E Anderson Lane in Austin, on or about August 1, 2027.

According to the company website, Artivion is a medical device company focused on developing solutions for cardiac and vascular surgeons treating diseases of the aorta. The company collaborates with leading surgeons to create innovative, aortic-focused technologies designed to improve surgical outcomes and help patients recover from life-threatening aortic conditions. Its portfolio includes heart valves, aortic prostheses, stent graft systems, vascular grafts, surgical patches, guidewires, balloons, and other cardiac and vascular products. Artivion positions itself as a specialized leader in aortic care, emphasizing breakthrough technologies and solutions with far-reaching impact. The company states that its AMDS Hybrid Prosthesis is the worlds first aortic arch remodeling device for treating acute DeBakey Type I aortic dissections. In June 2026, Artivion announced U.S. FDA approval of the AMDS Hybrid Prosthesis, following an FDA Humanitarian Device Exemption granted in December 2024.

To learn more, visit https://artivion.com/

Company Contact:
Artivion
1655 Roberts Boulevard NW
Kennesaw, GA30144
Phone: 770-419-3355
LinkedIn Link: https://www.linkedin.com/company/artivion

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.